Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05785182 · ClinicalTrials.gov registry record
OCT in Open Fracture and Infected Fracture
A clinical trial of Trauma and Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05785182: Recruiting study of Trauma and Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05785182 is a study of Trauma and Trauma Injury that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 40 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05785182, a study of Trauma and Trauma Injury, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.
Primary Outcome
The primary objective of this work is to demonstrate feasibility, acceptability, and preliminary effectiveness of Optical Coherence Tomography (OCT) to image bacteria and biofilm. Data will be analyzed accordingly: The association between optical imaging parameters (particularly around biofilm and bacterial contamination) and (1) surgical wound severity and (2) development of infection or treatment failure for infection.
Conditions Studied
Interventions
- PROCEDURE Open Fracture
- PROCEDURE Infected Fracture
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2027-06 |
What NCT05785182 shows while recruiting
NCT05785182 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower).
The record links to 4 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Open Fracture is the first listed.
NCT05785182 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05785182 about?
NCT05785182 is a clinical study titled "OCT in Open Fracture and Infected Fracture". This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.
What is the current status of trial NCT05785182?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-03-27. Estimated completion is 2027-06.
What conditions does trial NCT05785182 study?
This clinical trial studies the following conditions: Trauma, Trauma Injury, Open Fracture, Fracture Infection.
What interventions are being tested in trial NCT05785182?
The interventions under investigation include: Open Fracture (PROCEDURE), Infected Fracture (PROCEDURE).
Who is sponsoring clinical trial NCT05785182?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05785182 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05785182's enrollment target sits among peer trials
40 43rd of 56 higher than 11 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI